Food and Drug Administration

Risk Communication Advisory Committee

April 30 – May 1, 2009

FDA

Meeting Topic Both Days: Points to consider regarding the FDA’s draft Risk Communication Strategic Plan and Risk Communication Research Needs.

 April 30, 2009

Strategic Planning at FDA
Malcolm J. Bertoni, M.S., Assistant Commissioner for Planning (pdf) ) (ppt)

Goal:  Expand FDA’s Capacity to Generate and Oversee Risk Communication
Susan C. Winckler, RPh, Esq., Chief of Staff (pdf) (ppt)

Communication Planning Across the Continuum of Risk
AnnaMaria DeSalva (pdf) (ppt)

Goal:  Optimize FDA’s Policies on Communicating Product Risks and Benefits
Jeffrey Shuren, M.D., J.D., Associate Commissioner for Policy and Planning (pdf) (ppt)

Goal:  Strengthen the Science Supporting Effective Risk Communication
Nancy M. Ostrove, Ph.D., Director for Risk Communication (pdf) (ppt)

Perspective:  Select Models for Conducting Research Needed by Government Agencies
Baruch Fischhoff, Ph.D., Professor, Carnegie Mellon University (pdf) (ppt)

 May 1, 2009

Prioritization of Risk Communication Research
Nancy M. Ostrove, Ph.D., Director for Risk Communication (pdf) (ppt)

 Open Public Hearing, May 1, 2009

Julie L. Aker, President and CEO, Concentrics Research, LLC (pdf) (ppt)

 Committee Discussion

DRAFT for Discussion: Recommendations to FDA (pdf)

FINAL (unanimous) Recommendations to FDA (pdf)

---

Up | AC Home Page